ClinicalTrials.Veeva

Menu

Evaluating the Feasibility of Disseminating a Novel Mobile Platform to Treat Depression (PRIME-D)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Withdrawn

Conditions

Depression

Treatments

Behavioral: PRIME 1.0
Behavioral: PRIME 2.0

Study type

Interventional

Funder types

Other

Identifiers

NCT02817672
1R34MH110583-01

Details and patient eligibility

About

The goal of this project is to conduct a pilot study to test the utility of a Natural Language Processing (NLP) clinical messaging tool to improve the reach and the quality (fidelity and competency) of coaches providing behavioral activation (BA) strategies through a mobile mental health app called Personalized Real-time Intervention for Motivational Enhancement (PRIME). This study will improve the reach of clinicians by using a NLP-powered messaging tool, which will ensure fidelity to the BA model and clinicians will have access to real-time clinical information about their patients to guide more targeted treatment (competence). If successful, PRIME could operate as a cost effective tool for clinicians to extend their reach and an accessible treatment for the population of those struggling with depression.

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 and older
  • Read and speak English
  • PHQ-9 score of 5 or greater or indicate that their depressive symptoms are interfering with their daily functioning (Item 10 of the PHQ-9 > 2).
  • To be consistent with the NIMH RDoC initiative, we will assess for co-morbid problems (substance abuse, anxiety, and psychosis), but will not exclude participants with psychiatric comorbidities
  • Must own a mobile device on iOS or Android platforms that either Wi-Fi or 3G/4G ready;

Exclusion criteria

  • Under 18
  • Cannot read or speak in English
  • Cannot attain suitable mobile device

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

0 participants in 2 patient groups

PRIME 1.0
Active Comparator group
Description:
8 weeks use of PRIME 1.0 (current version). Mobile application designed to improve psychosocial functioning and motivational deficits.
Treatment:
Behavioral: PRIME 1.0
PRIME 2.0
Experimental group
Description:
8 weeks use of PRIME 2.0 (version with the NLP-powered dashboard). Mobile application designed to improve psychosocial functioning and motivational deficits.
Treatment:
Behavioral: PRIME 2.0

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems